These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Swimming exercise training-induced left ventricular hypertrophy involves microRNAs and synergistic regulation of the PI3K/AKT/mTOR signaling pathway. Ma Z; Qi J; Meng S; Wen B; Zhang J Eur J Appl Physiol; 2013 Oct; 113(10):2473-86. PubMed ID: 23812090 [TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor I receptor signaling is required for exercise-induced cardiac hypertrophy. Kim J; Wende AR; Sena S; Theobald HA; Soto J; Sloan C; Wayment BE; Litwin SE; Holzenberger M; LeRoith D; Abel ED Mol Endocrinol; 2008 Nov; 22(11):2531-43. PubMed ID: 18801929 [TBL] [Abstract][Full Text] [Related]
4. A novel traditional Chinese medicine ameliorates fatigue-induced cardiac hypertrophy and dysfunction via regulation of energy metabolism. Huang R; Cui YC; Wei XH; Pan CS; Li Q; He SY; Fan JY; Han JY Am J Physiol Heart Circ Physiol; 2019 Jun; 316(6):H1378-H1388. PubMed ID: 30951366 [TBL] [Abstract][Full Text] [Related]
5. Coupling factor 6-induced activation of ecto-F1F(o) complex induces insulin resistance, mild glucose intolerance and elevated blood pressure in mice. Osanai T; Tanaka M; Magota K; Tomita H; Okumura K Diabetologia; 2012 Feb; 55(2):520-9. PubMed ID: 22038518 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of coupling factor 6 causes cardiac dysfunction under high-salt diet in mice. Ashitate T; Osanai T; Tanaka M; Magota K; Echizen T; Izumiyama K; Yokoyama H; Shibutani S; Hanada K; Tomita H; Okumura K J Hypertens; 2010 Nov; 28(11):2243-51. PubMed ID: 20811295 [TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor I-mediated skeletal muscle hypertrophy is characterized by increased mTOR-p70S6K signaling without increased Akt phosphorylation. Song YH; Godard M; Li Y; Richmond SR; Rosenthal N; Delafontaine P J Investig Med; 2005 Apr; 53(3):135-42. PubMed ID: 15921033 [TBL] [Abstract][Full Text] [Related]
8. FoxO1 is required for physiological cardiac hypertrophy induced by exercise but not by constitutively active PI3K. Weeks KL; Tham YK; Yildiz SG; Alexander Y; Donner DG; Kiriazis H; Harmawan CA; Hsu A; Bernardo BC; Matsumoto A; DePinho RA; Abel ED; Woodcock EA; McMullen JR Am J Physiol Heart Circ Physiol; 2021 Apr; 320(4):H1470-H1485. PubMed ID: 33577435 [TBL] [Abstract][Full Text] [Related]
9. The IGF1-PI3K-Akt Signaling Pathway in Mediating Exercise-Induced Cardiac Hypertrophy and Protection. Weeks KL; Bernardo BC; Ooi JYY; Patterson NL; McMullen JR Adv Exp Med Biol; 2017; 1000():187-210. PubMed ID: 29098623 [TBL] [Abstract][Full Text] [Related]
10. Deletion of ribosomal S6 kinases does not attenuate pathological, physiological, or insulin-like growth factor 1 receptor-phosphoinositide 3-kinase-induced cardiac hypertrophy. McMullen JR; Shioi T; Zhang L; Tarnavski O; Sherwood MC; Dorfman AL; Longnus S; Pende M; Martin KA; Blenis J; Thomas G; Izumo S Mol Cell Biol; 2004 Jul; 24(14):6231-40. PubMed ID: 15226426 [TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor-1 receptor-mediated inhibition of A-type K(+) current induces sensory neuronal hyperexcitability through the phosphatidylinositol 3-kinase and extracellular signal-regulated kinase 1/2 pathways, independently of Akt. Wang H; Qin J; Gong S; Feng B; Zhang Y; Tao J Endocrinology; 2014 Jan; 155(1):168-79. PubMed ID: 24080365 [TBL] [Abstract][Full Text] [Related]
12. Pressure-mediated hypertrophy and mechanical stretch induces IL-1 release and subsequent IGF-1 generation to maintain compensative hypertrophy by affecting Akt and JNK pathways. Honsho S; Nishikawa S; Amano K; Zen K; Adachi Y; Kishita E; Matsui A; Katsume A; Yamaguchi S; Nishikawa K; Isoda K; Riches DW; Matoba S; Okigaki M; Matsubara H Circ Res; 2009 Nov; 105(11):1149-58. PubMed ID: 19834007 [TBL] [Abstract][Full Text] [Related]
13. Induction of myocardial insulin-like growth factor-I gene expression in left ventricular hypertrophy. Donohue TJ; Dworkin LD; Lango MN; Fliegner K; Lango RP; Benstein JA; Slater WR; Catanese VM Circulation; 1994 Feb; 89(2):799-809. PubMed ID: 8313569 [TBL] [Abstract][Full Text] [Related]
14. Activation or inactivation of cardiac Akt/mTOR signaling diverges physiological from pathological hypertrophy. Kemi OJ; Ceci M; Wisloff U; Grimaldi S; Gallo P; Smith GL; Condorelli G; Ellingsen O J Cell Physiol; 2008 Feb; 214(2):316-21. PubMed ID: 17941081 [TBL] [Abstract][Full Text] [Related]
16. Protective effects of exercise and phosphoinositide 3-kinase(p110alpha) signaling in dilated and hypertrophic cardiomyopathy. McMullen JR; Amirahmadi F; Woodcock EA; Schinke-Braun M; Bouwman RD; Hewitt KA; Mollica JP; Zhang L; Zhang Y; Shioi T; Buerger A; Izumo S; Jay PY; Jennings GL Proc Natl Acad Sci U S A; 2007 Jan; 104(2):612-7. PubMed ID: 17202264 [TBL] [Abstract][Full Text] [Related]
17. Deletion of IGF-1 Receptors in Cardiomyocytes Attenuates Cardiac Aging in Male Mice. Ock S; Lee WS; Ahn J; Kim HM; Kang H; Kim HS; Jo D; Abel ED; Lee TJ; Kim J Endocrinology; 2016 Jan; 157(1):336-45. PubMed ID: 26469138 [TBL] [Abstract][Full Text] [Related]